G Protein Coupled Receptor Agonists and Antagonists and Methods of Use

摘要

#$%^&*AU2010202328B220121213.pdf#####ABSTRACT The invention relates generally to G protein coupled receptors (GPCRs) and in particular to GPCR agonists and antagonists, use of these compounds and their pharmaceutical compositions, e.g., in the treatment, modulation and/or prevention of physiological conditions 5 associated with GPCRs, such as in treating conditions in which chemokine receptors play a role, e.g., sepsis, arthritis, inflammation and autoimmune diseases.1/28 z U 04 LL V 0)